Mark J Foley has bought stock on 2 days since Nov 2017

CEO at Revance Therapeutics, Inc., and 2 other companies

SEC CIK 0001529196 · Filings on SEC.gov ↗

$749KBought

$16.2MSold

Mar 8Last buy

Mark J Foley's record

3 months after each buy, from the first price a copier could get.

No buys have 3 months of prices yet. A record shows here at 3.

Companies

Every filing

23 filings since Jan 2016, newest first

RVNCBuy

Revance Therapeutics, Inc.

CEO

$209K+3.0%Mar 8

GKOSSell

Glaukos Corp

Director

$423K−12.0%Feb 26

RVNCSell

Revance Therapeutics, Inc.

CEO

$593K−3.0%Aug 4

RVNCSell

Revance Therapeutics, Inc.

CEO

$655K−3.0%Jul 5

RVNCSell

Revance Therapeutics, Inc.

CEO

$961K−3.0%Jun 13

RVNCSell

Revance Therapeutics, Inc.

CEO

$2.4M−6.0%May 16

RVNCSell

Revance Therapeutics, Inc.

CEO

$2.2M−7.0%Mar 9

RVNCBuy

Revance Therapeutics, Inc.

Director

$539K+333.0%Nov 9

ZLTQSell

Zeltiq Aesthetics Inc

President and CEO

$558K−5.0%Mar 14

ZLTQSell

Zeltiq Aesthetics Inc

President and CEO

$557K−4.0%Feb 15

ZLTQSell

Zeltiq Aesthetics Inc

President and CEO

$417K−4.0%Jan 17

ZLTQSell

Zeltiq Aesthetics Inc

President and CEO

$441K−4.0%Dec 15

ZLTQSell

Zeltiq Aesthetics Inc

President and CEO

$395K−4.0%Nov 15

ZLTQSell

Zeltiq Aesthetics Inc

President and CEO

$405K−4.0%Oct 14

ZLTQSell

Zeltiq Aesthetics Inc

President and CEO

$377K−3.0%Sep 14

ZLTQSell

Zeltiq Aesthetics Inc

President and CEO

$373K−3.0%Aug 16

ZLTQSell

Zeltiq Aesthetics Inc

President and CEO

$1.9M−14.0%Aug 10

ZLTQSell

Zeltiq Aesthetics Inc

President and CEO

$1.8M−14.0%Aug 8

ZLTQSell

Zeltiq Aesthetics Inc

President and CEO

$312K−3.0%Jul 14

ZLTQSell

Zeltiq Aesthetics Inc

President and CEO

$401K−4.0%Apr 14

ZLTQSell

Zeltiq Aesthetics Inc

President and CEO

$243K−3.0%Mar 23

ZLTQSell

Zeltiq Aesthetics Inc

President and CEO

$440K−5.0%Mar 22

ZLTQSell

Zeltiq Aesthetics Inc

President and CEO

$360K−4.0%Jan 14

Filings come from SEC EDGAR. Not investment advice.